Tensive
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$56.2K
LATEST DEAL AMOUNT
6
INVESTORS
Description
Developer of vascularizable biodebradable prostheses designed to offer a natural breast reconstruction or augmentation. The company's vascularizable biodebradable prostheses offers porous implantable prostheses based on biodegradable synthetic biomaterials and fabricated with internal mirco-channels mimicking the blood-vessels architecture for the treatment of breast cancer, enabling breast cancer patients to improve their quality of life and avoid recurrent and expensive surgical operations.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Viale Ortles 22/4
- 20139 Milan
- Italy
+39 02 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Tensive’s full profile, request a free trial.
Tensive Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 20-Jun-2016 | $56.2K | 00.000 | Completed | Pre-Clinical Trials | |
| 2. Early Stage VC | 20-May-2016 | 00.000 | 00.000 | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 01-Jan-2012 | Completed | Pre-Clinical Trials |
Tensive Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Horizon 2020 | Government | 000 0000 | 000000 0 | |||
| Invitalia Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Marzotto Family | Family Office | Minority | 000 0000 | 000000 0 | ||
| Rancilio Cube | Family Office | Minority | 000 0000 | 000000 0 | ||
| UniCredit | Investment Bank | Minority | 000 0000 | 000000 0 |
Tensive Executive Team (6)
You’re viewing 5 of 6 executives. Get the full list »Tensive Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alberto Cantaluppi MD | Tensive | Chairman | 000 0000 | |
| Alessandro Tocchio Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| Irini Gerges Ph.D | Tensive | Co-Founder, Chief Technology Officer & Director, Research & Development & Board Member | 000 0000 | |
| Mario Salerno Ph.D | Self | Board Member | 000 0000 |